mhurhangee/ep-ind-claims huggingface dataset:
A particulate product comprising lactate-coated particles, wherein the product contains at least 10 wt.% of lactate-coated particles having the following characteristics: • comprising one or more carrier particles containing at least 80 wt.% of one or more C 1-2 alkane carboxylates, said one or more C 1-2 alkane carboxylates being selected from anhydrous and hydrated metal salts of C 1-2 alkane carboxylic acid, the metal of said metal salts being a cation of a metal selected from sodium, potassium, calcium and combinations thereof; • comprising a coating layer that covers the one or more carrier particles, said coating layer containing at least 80 wt.% of sodium lactate; • containing the one or more C 1-2 alkane carboxylates and sodium lactate in a weight ratio of 1:2 to 2:1; and • having a particle size in the range of 40 to 1,500 μm as measured using laser diffraction. • comprising one or more carrier particles containing at least 80 wt.% of one or more C 1-2 alkane carboxylates, said one or more C 1-2 alkane carboxylates being selected from anhydrous and hydrated metal salts of C 1-2 alkane carboxylic acid, the metal of said metal salts being a cation of a metal selected from sodium, potassium, calcium and combinations thereof; • comprising a coating layer that covers the one or more carrier particles, said coating layer containing at least 80 wt.% of sodium lactate; • containing the one or more C 1-2 alkane carboxylates and sodium lactate in a weight ratio of 1:2 to 2:1; and • having a particle size in the range of 40 to 1,500 μm as measured using laser diffraction.
An optical device for intercanopy lighting, comprising: a light input area for receiving light from a light source; a first surface having a first rational quadratic bezier curve; and a second surface having a second rational quadratic bezier curve, said first and second rational quadratic bezier curves being independently selected with respect to each other, and arranged such that said optical device is rotational asymmetric with respect to its centre axis, wherein received light being reflected in said first surface is reflected in a direction towards said centre axis, and wherein received light being reflected in said second surface is reflected in a direction away from said centre axis, to thereby provide an asymmetric vertical intensity distribution exiting the optical device, such that at a pre-defined area, said area being illuminated under an angle, there is provided vertical and horizontal homogeneous illumination. a light input area for receiving light from a light source; a first surface having a first rational quadratic bezier curve; and a second surface having a second rational quadratic bezier curve, said first and second rational quadratic bezier curves being independently selected with respect to each other, and arranged such that said optical device is rotational asymmetric with respect to its centre axis, wherein received light being reflected in said first surface is reflected in a direction towards said centre axis, and wherein received light being reflected in said second surface is reflected in a direction away from said centre axis, to thereby provide an asymmetric vertical intensity distribution exiting the optical device, such that at a pre-defined area, said area being illuminated under an angle, there is provided vertical and horizontal homogeneous illumination.
Electronic memory arrangement comprising at least three memory areas (A, B, C), a memory control unit and at least two memory-accessing units (5, 6), wherein at least one memory-accessing unit can carry out write accesses and at least the other memory-accessing unit can carry out read accesses and wherein the memory control unit determines the accesses to the at least three memory areas (A, B, C), wherein the memory control unit is designed in such a manner that after the writing of a data packet to one of the three memory areas (A, B, C), the following data packet to be written is written to a memory area to which no read access takes place simultaneously during this subsequent write access, characterized in that the memory arrangement is constructed in accordance with a selecting-reading "sample mode", wherein after the transmission of a data freeze signal by a reading memory-accessing unit to the memory control unit, data are preserved in one of the memory areas (A, B, C) in unchanged form for a defined period, whereupon the further write access to the memory area last written to is prevented and/or blocked by the memory control unit until the desired data have been read out of this memory area at a later time or until a new data freeze signal is sent by the reading memory-accessing unit, wherein this write access must be concluded.
An operating fluid container made of thermoplastic material for a motor vehicle, having the following features: - the operating fluid container has a container opening which is arranged in a container wall and is edged by a surround; - the operating fluid container comprises at least one fastening device, which is arranged in the operating fluid container and is connected to a container base located opposite the container opening; - the operating fluid container further comprises a stiffening element, which is connectable and/or connected to a closure element for closing the container opening and is connectable to the fastening device; - the stiffening element which is fastened to the container base by means of the fastening device and to the container wall by means of the closure element counteracts deformation caused by the internal pressure of the operating fluid container, wherein the operating fluid container is characterized in that the operating fluid container further comprises a further fastening device connected to the container base and a fluid conveying unit, which is connectable and/or connected to the container base by means of the further fastening device. - the operating fluid container has a container opening which is arranged in a container wall and is edged by a surround; - the operating fluid container comprises at least one fastening device, which is arranged in the operating fluid container and is connected to a container base located opposite the container opening; - the operating fluid container further comprises a stiffening element, which is connectable and/or connected to a closure element for closing the container opening and is connectable to the fastening device; - the stiffening element which is fastened to the container base by means of the fastening device and to the container wall by means of the closure element counteracts deformation caused by the internal pressure of the operating fluid container,
A multipurpose valve tool comprising: - a plurality of flow control discs configured to be installed within a valve body of a valve assembly to modulate a flow of fluid through at least one outlet port (2408, 2410, 3102) of the valve body; - a retention ring configured to retain the plurality of flow control discs on a component of the valve assembly when the plurality of flow control discs are not installed within the valve body; and - a valve key having a first end configured to engage an installation feature in a retention fastener for one of the plurality of flow control discs; wherein the plurality of flow control discs, the retention ring, and the valve key are detachably coupled to each other. - a plurality of flow control discs configured to be installed within a valve body of a valve assembly to modulate a flow of fluid through at least one outlet port (2408, 2410, 3102) of the valve body; - a retention ring configured to retain the plurality of flow control discs on a component of the valve assembly when the plurality of flow control discs are not installed within the valve body; and - a valve key having a first end configured to engage an installation feature in a retention fastener for one of the plurality of flow control discs; wherein the plurality of flow control discs, the retention ring, and the valve key are detachably coupled to each other.
A pharmaceutical composition or dietary supplement comprising, as the active ingredients, the combination of curcumin, alpha-lipoic acid and L-tryptophan, for use in the treatment and prevention of pathologies associated with climacteric and menopause, said pathologies being selected from the group consisting of glucose-lipid dysmetabolism, body weight modification, general tissue ageing, and combinations thereof, or in the prevention of tumours.
A method for preparing a composition comprising highly concentrated antibodies by tangential flow ultrafiltration, wherein the highly concentrated antibodies have a protein concentration of above 200 g/L, wherein the method comprises the steps of: 1) regulating the feed flow rate such that the maximum value of feed pressure applied to the ultrafiltration membrane is 85-100% of the specified maximum feed pressure of the ultrafiltration membrane, wherein the feed flow rate is maintained at 250 LMH (L/m 2 /hour) or higher; and 2) decreasing the feed flow rate to decrease the value of the feed pressure applied to the ultrafiltration membrane after the step, which decreased feed flow rate is maintained at a constant rate of 80 LMH (L/m 2 /hour) or lower; wherein step is transitioned to step when the retentate solution is concentrated to a protein concentration greater than 200 g/L; wherein the antibody preparation is recirculated between step and step through the membrane with the permeate valve closed at a constant flow rate between 10 to 80 LMH (L/m 2 /hour) with the retentate pressure control valve fully open; wherein the method operates with the permeate side open-ended; and wherein the transmembrane pressure is controlled at 1.0 bar until the retentate pressure control valve becomes fully open. 1) regulating the feed flow rate such that the maximum value of feed pressure applied to the ultrafiltration membrane is 85-100% of the specified maximum feed pressure of the ultrafiltration membrane, wherein the feed flow rate is maintained at 250 LMH (L/m 2 /hour) or higher; and 2) decreasing the feed flow rate to decrease the value of the feed pressure applied to the ultrafiltration membrane after the step, which decreased feed flow rate is maintained at a constant rate of 80 LMH (L/m 2 /hour) or lower; wherein step is transitioned to step when the retentate solution is concentrated to a protein concentration greater than 200 g/L; wherein the antibody preparation is recirculated between step and step through the membrane with the permeate valve closed at a constant flow rate between 10 to 80 LMH (L/m 2 /hour) with the retentate pressure control valve fully open; wherein the method operates with the permeate side open-ended; and wherein the transmembrane pressure is controlled at 1.0 bar until the retentate pressure control valve becomes fully open.
Thermoplastic molded injected tip structure for an aircraft, wherein the tip structure is a thermoplastic unitary body comprising an interface area configured to be attached to a torsion box, wherein the tip structure has been manufactured either by a single-stage injection process, or the tip structure is formed by two or more parts, each part obtained by an injection process, with an additional melt-stage to attach the parts to each other; characterized in that the thermoplastic unitary body further comprises a conductive material suitable to withstand a lighting strike event; wherein the tip structure further comprises: - a tip shell, wherein the conductive material is either a metallic material or a doped resin material, located on the outer surface of the tip shell suitable to withstand a lighting strike; - a reinforcing structure internally fitted inside the tip shell to reinforce the same, wherein said reinforcing structure has been obtained during the same injection molding process together with the tip shell using the same material; and - at least one local reinforcement in the form of a ply of continuous carbon fiber composite material. - a tip shell, wherein the conductive material is either a metallic material or a doped resin material, located on the outer surface of the tip shell suitable to withstand a lighting strike; - a reinforcing structure internally fitted inside the tip shell to reinforce the same, wherein said reinforcing structure has been obtained during the same injection molding process together with the tip shell using the same material; and - at least one local reinforcement in the form of a ply of continuous carbon fiber composite material.
A method of diagnosing a prostate condition in a subject, comprising: determining, in a sample obtained from a subject comprising prostatic fluid, expressed prostatic secretion or seminal fluid, levels of a combination of a plurality of constituents, wherein the combination of constituents is selected from the group consisting of Ca/Fe, Mg/AI, Ca/Cu, Mg/Cu, Ca/Mn, Ca/AI, Ca/Ba, Zn/Mn, Ca/P, Ca/Si, Ca/Sr, (Ca/Cu)*(Mg/Cu), (Ca/Cu)*(Zn/Cu), (Mg/Cu)*(Zn/Cu), (Ca*Mg*Zn)/(Al*Bi*Cu), (Ca*Mg*Zn)/(Mn*Bi*Se), (Zn*Ca*Mg*Cd)/(Si*Br*Al*Ba), (Zn*Rb)/10, (Ca n *Cd n *Co n *Hg n *K n *Mg n *Na n *P n *Rb n *S n *Sc n *Se n *Zn n)/(Ag n *Al n *Au n *B n *Ba n *Bi n *Br n *Ce n *Cr n * Cs n *Cu n *Dy n *Er n *Fe n *Gd n *Ho n *La n *Li n *Mn n *Nd n *Ni n *Pb n *Pr n *Sb n *Si n *Sm n *Sr n *Th n *Tl n *U n *Y n *Zr n), (Ca n *Cd n *Co n *Hg n *K n *Mg n *Na n *P n *Rb n *S n *Se n *Zn n)/(Ag n *Al n *Ba n *Bi n *Br n *Ce n *Cr n *Cs n *Cu n *Li n * Mn n *Ni n *Pb n *Sb n *Si n *Sr n), (Ca n *K n *Mg n *Rb n *S n *Zn n)/6, (Ca n *K n *Mg n *Zn n)/4 or (Ca n +K n +Mg n +Zn n)-4, wherein n indicates a normalized level; and comparing the levels of the combination of the plurality of constituents in the sample with control levels of the same combination of plurality of constituents, in which a difference between the combinations is indicative of the prostate condition.
An assembly for forming an air-guiding element for a motor vehicle, comprising a shell-shaped air-guiding body and a brake lamp, wherein the air-guiding body has an elongated opening which extends through the air-guiding body; so as to form an air-guiding element, the elongated opening can be closed off at least in regions by a light emitting surface of the brake lamp by disposing the brake lamp in a predetermined brake lamp position, wherein in the predetermined brake lamp position, the brake lamp is enclosed at least in regions by the air-guiding body; wherein at least one retention element is integrally formed on a retention side of an air-guiding body portion of the air-guiding body, and at least one counterpart retention element is integrally formed on a retention side of the brake lamp; wherein the retention element can be retained on the counterpart retention element so as to retain the air-guiding body on the brake lamp in the predetermined brake lamp position; wherein, in the connected state of the air-guiding element and the motor vehicle, the air-guiding body portion is arranged below the brake lamp, and the retention side of the air-guiding body portion faces toward the retention side of the brake lamp, characterized in that both the retention element and the counterpart retention element have a hook-shaped design, the counterpart retention element and the retention element can be hooked into each other so as to retain the air-guiding body on the brake lamp in the predetermined brake lamp position.
A catheter pump assembly, comprising: an impeller assembly, a catheter body coupled with the proximal end of the impeller assembly, the catheter body having a reduced stiffness section disposed proximally of the impeller assembly; and a sheath assembly, the sheath assembly configured to be translated over the catheter body relative to the impeller assembly from an impeller assembly delivery position to an impeller assembly deployment position, wherein said sheath assembly includes a variable stiffness along its length to cause a restoring force to bear on a vessel contact zone and maintain the position of the catheter pump assembly in the aortic arch when the sheath assembly is in the impeller assembly deployment position, and wherein, when the sheath assembly is in the impeller assembly deployment position, a reduction in stiffness is provided between the distal end of the sheath assembly and the impeller assembly. an impeller assembly, a catheter body coupled with the proximal end of the impeller assembly, the catheter body having a reduced stiffness section disposed proximally of the impeller assembly; and a sheath assembly, the sheath assembly configured to be translated over the catheter body relative to the impeller assembly from an impeller assembly delivery position to an impeller assembly deployment position, wherein said sheath assembly includes a variable stiffness along its length to cause a restoring force to bear on a vessel contact zone and maintain the position of the catheter pump assembly in the aortic arch when the sheath assembly is in the impeller assembly deployment position, and wherein, when the sheath assembly is in the impeller assembly deployment position, a reduction in stiffness is provided between the distal end of the sheath assembly and the impeller assembly.
A method of forming a dry floor assembly, the method comprising: cleaning an upper layer with methyl ethyl ketone prior to bonding the upper layer to a carbon wicking layer, wherein said cleaning removes release agent from the upper layer; and bonding the upper layer to the carbon wicking layer after said cleaning. cleaning an upper layer with methyl ethyl ketone prior to bonding the upper layer to a carbon wicking layer, wherein said cleaning removes release agent from the upper layer; and bonding the upper layer to the carbon wicking layer after said cleaning.
A pharmaceutical composition comprising a recombinant MVA virus expressing an HIV env, gag-pol gene or modified gene thereof for production of an HIV Env, Gag-Pol antigen by expression from said recombinant MVA virus, wherein said HIV env gene is modified to encode an HIV Env protein composed of gp120 and the membrane-spanning and ectodomain of gp41 but lacking part or all of the cytoplasmic domain of gp41, and a pharmaceutically acceptable carrier; wherein said HIV env, gag-pol gene or modified gene thereof is taken from clade AG and said HIV env gene or modified gene thereof is at least 97% identical to the sequence set forth in Figure 12, and said HIV gag-pol gene or modified gene thereof is at least 97% identical to the sequence set forth in Figure 13, and wherein the pol gene encodes an asparagine at amino acid 185 of reverse transcriptase, a threonine at amino acid 266 of reverse transcriptase and a glutamine at amino acid 478 of reverse transcriptase; or said HIV env, gag-pol gene or modified gene thereof is taken from clade B and said HIV env gene or modified gene thereof is at least 97% identical to the sequence set forth in Figure 23, and said HIV gag-pol gene or modified gene thereof is at least 97% identical to the sequence set forth in Figure 24, and wherein the pol gene encodes an asparagine at amino acid 185 of reverse transcriptase, a threonine at amino acid 266 of reverse transcriptase and a glutamine at amino acid 478 of reverse transcriptase; or said HIV env, gag-pol gene or modified gene thereof is taken from clade C and said HIV env gene or modified gene thereof is at least 97% identical to the sequence set forth in Figure 39, and said HIV gag-pol gene or modified gene thereof is at least 97% identical to the sequence set forth in Figure 40, and wherein the pol gene encodes an asparagine at amino acid 185 of reverse transcriptase, a threonine at amino acid 266 of reverse transcriptase and a glutamine at amino acid 478 of reverse transcriptase; wherein said env gene is inserted into deletion II of the MVA virus and said gag-pol gene is inserted into deletion III of the MVA virus; and wherein said env gene and said gag-pol genes are under the control of the mH5 promoter.
A removable tubing cartridge for aligning a pump segment tubing within an infusion pump, the cartridge comprising: an elongated cartridge body comprising an upper end and a lower end; an upper lip disposed about the upper end of the cartridge body, wherein the upper lip extends axially away from the cartridge body in a first direction; at least one lower fastener disposed about the lower end of the cartridge body, wherein the at least one lower fastener extends axially away from the cartridge body in the first direction and the upper lip and the at least one lower fastener are configured to cooperatively align the cartridge body within the infusion pump; characterized by: an upper tubing adapter cavity formed in the upper lip, the upper tubing adapter cavity having a mating profile defining an opening of the upper tubing adapter cavity to receive an upper tubing adapter, wherein the mating profile defines a generally semi-circular mating profile extending from an edge of the upper lip toward the cartridge body; and a lower tubing adapter cavity formed in the cartridge body, wherein the lower tubing adapter cavity is longitudinally spaced apart from the upper tubing adapter cavity and the upper tubing adapter cavity and the lower tubing adapter cavity are configured to cooperatively align the pump segment tubing relative to the cartridge body. an upper tubing adapter cavity formed in the upper lip, the upper tubing adapter cavity having a mating profile defining an opening of the upper tubing adapter cavity to receive an upper tubing adapter, wherein the mating profile defines a generally semi-circular mating profile extending from an edge of the upper lip toward the cartridge body; and a lower tubing adapter cavity formed in the cartridge body, wherein the lower tubing adapter cavity is longitudinally spaced apart from the upper tubing adapter cavity and the upper tubing adapter cavity and the lower tubing adapter cavity are configured to cooperatively align the pump segment tubing relative to the cartridge body.
A stainless steel bur (20, 30) comprising: a handle (21, 31), which includes an attachment (21a, 31a) connectable to a hand piece and a straight part (21b, 31b) for a rotating apparatus to grip, the handle being removably connectable to the hand piece on the base side; a working section (22, 32) to which a cutting blade (22a, 32a) for cutting teeth is attached to the tip; and an intermediate section between the working section (22, 32) and the handle (21, 31), at least part of the intermediate section (23, 33) having a tapered form, wherein the steel bur (20, 30) is hardened through wire drawing, made of austenitic stainless steel having a fibrous structure, and when the working section (22,32) is rotated and meets healthy dentin and/or enamel, vibrations are generated and/or cutting resistance increases, characterized in that a short diameter section and/or a hole is formed in the straight part of the handle (21, 31) within a range of one-third of the length of the handle (21, 31) from the intermediate section (23, 33) side end of the handle (21, 31). a handle (21, 31), which includes an attachment (21a, 31a) connectable to a hand piece and a straight part (21b, 31b) for a rotating apparatus to grip, the handle being removably connectable to the hand piece on the base side; a working section (22, 32) to which a cutting blade (22a, 32a) for cutting teeth is attached to the tip; and an intermediate section between the working section (22, 32) and the handle (21, 31), at least part of the intermediate section (23, 33) having a tapered form, wherein the steel bur (20, 30) is hardened through wire drawing, made of austenitic stainless steel having a fibrous structure, and when the working section (22,32) is rotated and meets healthy dentin and/or enamel, vibrations are generated and/or cutting resistance increases, characterized in that a short diameter section and/or a hole is formed in the straight part of the handle (21, 31) within a range of one-third of the length of the handle (21, 31) from the intermediate section (23, 33) side end of the handle (21, 31).